Market Tracker

06/24 5:16pm ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.28
Delayed Data
As of Jun 24
 -1.31 / -2.94%
Today’s Change
31.25
Today|||52-Week Range
58.46
-23.49%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close44.59
Today’s open42.20
Day’s range41.56 - 44.71
Volume8,931,812
Average volume (3 months)1,160,265
Market cap$3.9B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-29.63%
Earnings growth (this year)-85.83%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)--
P/E ratioNM
Price/Sales241.79
Price/Book9.06

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-11.34-7.35%
ACADACADIA Pharmaceutica...-2.07-6.18%
GRFSGrifols SA-0.58-3.61%
ENDPEndo International P...-0.99-6.25%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$19.8M
Annual profit (last year)-$88.9M
Net profit margin-449.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts